Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05265988
Title Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib (MERIDIAN)
Acronym MERIDIAN
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Alfredo Berruti
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries ITA

Facility Status City State Zip Country Details
Alfredo Berruti Brescia 25123 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field